The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Testosterone Transdermal System Market Research Report 2025
Synopsis
Testosterone Transdermal is a testosterone replacement that acts like the natural sex hormone.
The global Testosterone Transdermal System market was valued at US$ 142 million in 2023 and is anticipated to reach US$ 216.6 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Testosterone Transdermal System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Transdermal System.
Report Scope
The Testosterone Transdermal System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Testosterone Transdermal System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Transdermal System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan(Actavis)
AbbVie
Endo International
Aytu BioPharma
Upsher-Smith Laboratories
Kyowa Hakko Kirin Co., Ltd.
Besins Healthcare
Perrigo
TWi Pharmaceuticals
Segment by Type
Testosterone Patches
Testosterone Gels
Segment by Application
Online Sales
Drugstore Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Testosterone Transdermal System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Testosterone Transdermal System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Testosterone Transdermal is a testosterone replacement that acts like the natural sex hormone.
The global Testosterone Transdermal System market was valued at US$ 142 million in 2023 and is anticipated to reach US$ 216.6 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Testosterone Transdermal System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Transdermal System.
Report Scope
The Testosterone Transdermal System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Testosterone Transdermal System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Transdermal System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan(Actavis)
AbbVie
Endo International
Aytu BioPharma
Upsher-Smith Laboratories
Kyowa Hakko Kirin Co., Ltd.
Besins Healthcare
Perrigo
TWi Pharmaceuticals
Segment by Type
Testosterone Patches
Testosterone Gels
Segment by Application
Online Sales
Drugstore Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Testosterone Transdermal System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Testosterone Transdermal System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Testosterone Transdermal System Market Overview
1.1 Product Overview and Scope of Testosterone Transdermal System
1.2 Testosterone Transdermal System Segment by Type
1.2.1 Global Testosterone Transdermal System Market Value Comparison by Type (2024-2030)
1.2.2 Testosterone Patches
1.2.3 Testosterone Gels
1.3 Testosterone Transdermal System Segment by Application
1.3.1 Global Testosterone Transdermal System Market Value by Application: (2024-2030)
1.3.2 Online Sales
1.3.3 Drugstore Sales
1.4 Global Testosterone Transdermal System Market Size Estimates and Forecasts
1.4.1 Global Testosterone Transdermal System Revenue 2019-2030
1.4.2 Global Testosterone Transdermal System Sales 2019-2030
1.4.3 Global Testosterone Transdermal System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Testosterone Transdermal System Market Competition by Manufacturers
2.1 Global Testosterone Transdermal System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Testosterone Transdermal System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Testosterone Transdermal System Average Price by Manufacturers (2019-2024)
2.4 Global Testosterone Transdermal System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Testosterone Transdermal System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Testosterone Transdermal System, Product Type & Application
2.7 Testosterone Transdermal System Market Competitive Situation and Trends
2.7.1 Testosterone Transdermal System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Testosterone Transdermal System Players Market Share by Revenue
2.7.3 Global Testosterone Transdermal System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Testosterone Transdermal System Retrospective Market Scenario by Region
3.1 Global Testosterone Transdermal System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Testosterone Transdermal System Global Testosterone Transdermal System Sales by Region: 2019-2030
3.2.1 Global Testosterone Transdermal System Sales by Region: 2019-2024
3.2.2 Global Testosterone Transdermal System Sales by Region: 2025-2030
3.3 Global Testosterone Transdermal System Global Testosterone Transdermal System Revenue by Region: 2019-2030
3.3.1 Global Testosterone Transdermal System Revenue by Region: 2019-2024
3.3.2 Global Testosterone Transdermal System Revenue by Region: 2025-2030
3.4 North America Testosterone Transdermal System Market Facts & Figures by Country
3.4.1 North America Testosterone Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Testosterone Transdermal System Sales by Country (2019-2030)
3.4.3 North America Testosterone Transdermal System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Testosterone Transdermal System Market Facts & Figures by Country
3.5.1 Europe Testosterone Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Testosterone Transdermal System Sales by Country (2019-2030)
3.5.3 Europe Testosterone Transdermal System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Testosterone Transdermal System Market Facts & Figures by Country
3.6.1 Asia Pacific Testosterone Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Testosterone Transdermal System Sales by Country (2019-2030)
3.6.3 Asia Pacific Testosterone Transdermal System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Testosterone Transdermal System Market Facts & Figures by Country
3.7.1 Latin America Testosterone Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Testosterone Transdermal System Sales by Country (2019-2030)
3.7.3 Latin America Testosterone Transdermal System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Testosterone Transdermal System Market Facts & Figures by Country
3.8.1 Middle East and Africa Testosterone Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Testosterone Transdermal System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Testosterone Transdermal System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Testosterone Transdermal System Sales by Type (2019-2030)
4.1.1 Global Testosterone Transdermal System Sales by Type (2019-2024)
4.1.2 Global Testosterone Transdermal System Sales by Type (2025-2030)
4.1.3 Global Testosterone Transdermal System Sales Market Share by Type (2019-2030)
4.2 Global Testosterone Transdermal System Revenue by Type (2019-2030)
4.2.1 Global Testosterone Transdermal System Revenue by Type (2019-2024)
4.2.2 Global Testosterone Transdermal System Revenue by Type (2025-2030)
4.2.3 Global Testosterone Transdermal System Revenue Market Share by Type (2019-2030)
4.3 Global Testosterone Transdermal System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Testosterone Transdermal System Sales by Application (2019-2030)
5.1.1 Global Testosterone Transdermal System Sales by Application (2019-2024)
5.1.2 Global Testosterone Transdermal System Sales by Application (2025-2030)
5.1.3 Global Testosterone Transdermal System Sales Market Share by Application (2019-2030)
5.2 Global Testosterone Transdermal System Revenue by Application (2019-2030)
5.2.1 Global Testosterone Transdermal System Revenue by Application (2019-2024)
5.2.2 Global Testosterone Transdermal System Revenue by Application (2025-2030)
5.2.3 Global Testosterone Transdermal System Revenue Market Share by Application (2019-2030)
5.3 Global Testosterone Transdermal System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan(Actavis)
6.1.1 Allergan(Actavis) Corporation Information
6.1.2 Allergan(Actavis) Description and Business Overview
6.1.3 Allergan(Actavis) Testosterone Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan(Actavis) Testosterone Transdermal System Product Portfolio
6.1.5 Allergan(Actavis) Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Testosterone Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Testosterone Transdermal System Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Corporation Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Testosterone Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endo International Testosterone Transdermal System Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Aytu BioPharma
6.4.1 Aytu BioPharma Corporation Information
6.4.2 Aytu BioPharma Description and Business Overview
6.4.3 Aytu BioPharma Testosterone Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aytu BioPharma Testosterone Transdermal System Product Portfolio
6.4.5 Aytu BioPharma Recent Developments/Updates
6.5 Upsher-Smith Laboratories
6.5.1 Upsher-Smith Laboratories Corporation Information
6.5.2 Upsher-Smith Laboratories Description and Business Overview
6.5.3 Upsher-Smith Laboratories Testosterone Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Upsher-Smith Laboratories Testosterone Transdermal System Product Portfolio
6.5.5 Upsher-Smith Laboratories Recent Developments/Updates
6.6 Kyowa Hakko Kirin Co., Ltd.
6.6.1 Kyowa Hakko Kirin Co., Ltd. Corporation Information
6.6.2 Kyowa Hakko Kirin Co., Ltd. Description and Business Overview
6.6.3 Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Product Portfolio
6.6.5 Kyowa Hakko Kirin Co., Ltd. Recent Developments/Updates
6.7 Besins Healthcare
6.6.1 Besins Healthcare Corporation Information
6.6.2 Besins Healthcare Description and Business Overview
6.6.3 Besins Healthcare Testosterone Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Besins Healthcare Testosterone Transdermal System Product Portfolio
6.7.5 Besins Healthcare Recent Developments/Updates
6.8 Perrigo
6.8.1 Perrigo Corporation Information
6.8.2 Perrigo Description and Business Overview
6.8.3 Perrigo Testosterone Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Perrigo Testosterone Transdermal System Product Portfolio
6.8.5 Perrigo Recent Developments/Updates
6.9 TWi Pharmaceuticals
6.9.1 TWi Pharmaceuticals Corporation Information
6.9.2 TWi Pharmaceuticals Description and Business Overview
6.9.3 TWi Pharmaceuticals Testosterone Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 TWi Pharmaceuticals Testosterone Transdermal System Product Portfolio
6.9.5 TWi Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Testosterone Transdermal System Industry Chain Analysis
7.2 Testosterone Transdermal System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Testosterone Transdermal System Production Mode & Process
7.4 Testosterone Transdermal System Sales and Marketing
7.4.1 Testosterone Transdermal System Sales Channels
7.4.2 Testosterone Transdermal System Distributors
7.5 Testosterone Transdermal System Customers
8 Testosterone Transdermal System Market Dynamics
8.1 Testosterone Transdermal System Industry Trends
8.2 Testosterone Transdermal System Market Drivers
8.3 Testosterone Transdermal System Market Challenges
8.4 Testosterone Transdermal System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Testosterone Transdermal System Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Testosterone Transdermal System Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Testosterone Transdermal System Market Competitive Situation by Manufacturers in 2023
Table 4. Global Testosterone Transdermal System Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Testosterone Transdermal System Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Testosterone Transdermal System Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Testosterone Transdermal System Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Testosterone Transdermal System Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Testosterone Transdermal System, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Testosterone Transdermal System, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Testosterone Transdermal System, Product Type & Application
Table 12. Global Key Manufacturers of Testosterone Transdermal System, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Testosterone Transdermal System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Transdermal System as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Testosterone Transdermal System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Testosterone Transdermal System Sales by Region (2019-2024) & (K Units)
Table 18. Global Testosterone Transdermal System Sales Market Share by Region (2019-2024)
Table 19. Global Testosterone Transdermal System Sales by Region (2025-2030) & (K Units)
Table 20. Global Testosterone Transdermal System Sales Market Share by Region (2025-2030)
Table 21. Global Testosterone Transdermal System Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Testosterone Transdermal System Revenue Market Share by Region (2019-2024)
Table 23. Global Testosterone Transdermal System Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Testosterone Transdermal System Revenue Market Share by Region (2025-2030)
Table 25. North America Testosterone Transdermal System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Testosterone Transdermal System Sales by Country (2019-2024) & (K Units)
Table 27. North America Testosterone Transdermal System Sales by Country (2025-2030) & (K Units)
Table 28. North America Testosterone Transdermal System Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Testosterone Transdermal System Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Testosterone Transdermal System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Testosterone Transdermal System Sales by Country (2019-2024) & (K Units)
Table 32. Europe Testosterone Transdermal System Sales by Country (2025-2030) & (K Units)
Table 33. Europe Testosterone Transdermal System Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Testosterone Transdermal System Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Testosterone Transdermal System Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Testosterone Transdermal System Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Testosterone Transdermal System Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Testosterone Transdermal System Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Testosterone Transdermal System Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Testosterone Transdermal System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Testosterone Transdermal System Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Testosterone Transdermal System Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Testosterone Transdermal System Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Testosterone Transdermal System Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Testosterone Transdermal System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Testosterone Transdermal System Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Testosterone Transdermal System Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Testosterone Transdermal System Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Testosterone Transdermal System Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Testosterone Transdermal System Sales (K Units) by Type (2019-2024)
Table 51. Global Testosterone Transdermal System Sales (K Units) by Type (2025-2030)
Table 52. Global Testosterone Transdermal System Sales Market Share by Type (2019-2024)
Table 53. Global Testosterone Transdermal System Sales Market Share by Type (2025-2030)
Table 54. Global Testosterone Transdermal System Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Testosterone Transdermal System Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Testosterone Transdermal System Revenue Market Share by Type (2019-2024)
Table 57. Global Testosterone Transdermal System Revenue Market Share by Type (2025-2030)
Table 58. Global Testosterone Transdermal System Price (US$/Unit) by Type (2019-2024)
Table 59. Global Testosterone Transdermal System Price (US$/Unit) by Type (2025-2030)
Table 60. Global Testosterone Transdermal System Sales (K Units) by Application (2019-2024)
Table 61. Global Testosterone Transdermal System Sales (K Units) by Application (2025-2030)
Table 62. Global Testosterone Transdermal System Sales Market Share by Application (2019-2024)
Table 63. Global Testosterone Transdermal System Sales Market Share by Application (2025-2030)
Table 64. Global Testosterone Transdermal System Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Testosterone Transdermal System Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Testosterone Transdermal System Revenue Market Share by Application (2019-2024)
Table 67. Global Testosterone Transdermal System Revenue Market Share by Application (2025-2030)
Table 68. Global Testosterone Transdermal System Price (US$/Unit) by Application (2019-2024)
Table 69. Global Testosterone Transdermal System Price (US$/Unit) by Application (2025-2030)
Table 70. Allergan(Actavis) Corporation Information
Table 71. Allergan(Actavis) Description and Business Overview
Table 72. Allergan(Actavis) Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Allergan(Actavis) Testosterone Transdermal System Product
Table 74. Allergan(Actavis) Recent Developments/Updates
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. AbbVie Testosterone Transdermal System Product
Table 79. AbbVie Recent Developments/Updates
Table 80. Endo International Corporation Information
Table 81. Endo International Description and Business Overview
Table 82. Endo International Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Endo International Testosterone Transdermal System Product
Table 84. Endo International Recent Developments/Updates
Table 85. Aytu BioPharma Corporation Information
Table 86. Aytu BioPharma Description and Business Overview
Table 87. Aytu BioPharma Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Aytu BioPharma Testosterone Transdermal System Product
Table 89. Aytu BioPharma Recent Developments/Updates
Table 90. Upsher-Smith Laboratories Corporation Information
Table 91. Upsher-Smith Laboratories Description and Business Overview
Table 92. Upsher-Smith Laboratories Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Upsher-Smith Laboratories Testosterone Transdermal System Product
Table 94. Upsher-Smith Laboratories Recent Developments/Updates
Table 95. Kyowa Hakko Kirin Co., Ltd. Corporation Information
Table 96. Kyowa Hakko Kirin Co., Ltd. Description and Business Overview
Table 97. Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Product
Table 99. Kyowa Hakko Kirin Co., Ltd. Recent Developments/Updates
Table 100. Besins Healthcare Corporation Information
Table 101. Besins Healthcare Description and Business Overview
Table 102. Besins Healthcare Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Besins Healthcare Testosterone Transdermal System Product
Table 104. Besins Healthcare Recent Developments/Updates
Table 105. Perrigo Corporation Information
Table 106. Perrigo Description and Business Overview
Table 107. Perrigo Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Perrigo Testosterone Transdermal System Product
Table 109. Perrigo Recent Developments/Updates
Table 110. TWi Pharmaceuticals Corporation Information
Table 111. TWi Pharmaceuticals Description and Business Overview
Table 112. TWi Pharmaceuticals Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. TWi Pharmaceuticals Testosterone Transdermal System Product
Table 114. TWi Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Testosterone Transdermal System Distributors List
Table 118. Testosterone Transdermal System Customers List
Table 119. Testosterone Transdermal System Market Trends
Table 120. Testosterone Transdermal System Market Drivers
Table 121. Testosterone Transdermal System Market Challenges
Table 122. Testosterone Transdermal System Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Testosterone Transdermal System
Figure 2. Global Testosterone Transdermal System Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Testosterone Transdermal System Market Share by Type in 2023 & 2030
Figure 4. Testosterone Patches Product Picture
Figure 5. Testosterone Gels Product Picture
Figure 6. Global Testosterone Transdermal System Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Testosterone Transdermal System Market Share by Application in 2023 & 2030
Figure 8. Online Sales
Figure 9. Drugstore Sales
Figure 10. Global Testosterone Transdermal System Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Testosterone Transdermal System Market Size (2019-2030) & (US$ Million)
Figure 12. Global Testosterone Transdermal System Sales (2019-2030) & (K Units)
Figure 13. Global Testosterone Transdermal System Average Price (US$/Unit) & (2019-2030)
Figure 14. Testosterone Transdermal System Report Years Considered
Figure 15. Testosterone Transdermal System Sales Share by Manufacturers in 2023
Figure 16. Global Testosterone Transdermal System Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Testosterone Transdermal System Players: Market Share by Revenue in 2023
Figure 18. Testosterone Transdermal System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Testosterone Transdermal System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Testosterone Transdermal System Sales Market Share by Country (2019-2030)
Figure 21. North America Testosterone Transdermal System Revenue Market Share by Country (2019-2030)
Figure 22. United States Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Testosterone Transdermal System Sales Market Share by Country (2019-2030)
Figure 25. Europe Testosterone Transdermal System Revenue Market Share by Country (2019-2030)
Figure 26. Germany Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Testosterone Transdermal System Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Testosterone Transdermal System Revenue Market Share by Region (2019-2030)
Figure 33. China Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Testosterone Transdermal System Sales Market Share by Country (2019-2030)
Figure 43. Latin America Testosterone Transdermal System Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Testosterone Transdermal System Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Testosterone Transdermal System Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Testosterone Transdermal System Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Testosterone Transdermal System by Type (2019-2030)
Figure 53. Global Revenue Market Share of Testosterone Transdermal System by Type (2019-2030)
Figure 54. Global Testosterone Transdermal System Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Testosterone Transdermal System by Application (2019-2030)
Figure 56. Global Revenue Market Share of Testosterone Transdermal System by Application (2019-2030)
Figure 57. Global Testosterone Transdermal System Price (US$/Unit) by Application (2019-2030)
Figure 58. Testosterone Transdermal System Value Chain
Figure 59. Testosterone Transdermal System Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
